TuberQ: A Mycobacterium tuberculosis protein druggability database

Database

Volumn 2014, Issue , 2014, Pages

  Radusky, Leandro ^a   Defelipe, Lucas A ^a   Lanzarotti, Esteban ^a   Luque, Javier ^b   Barril, Xavier ^b,c   Marti, Marcelo A ^a   Turjanski, Adrián G ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; TUBERCULOSTATIC AGENT;

ARTICLE; CHEMISTRY; DATA BASE; INTERNET; METABOLISM; MYCOBACTERIUM TUBERCULOSIS; PROTEIN DATABASE; PROTEIN TERTIARY STRUCTURE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DATABASE MANAGEMENT SYSTEMS; DATABASES, PROTEIN; INTERNET; MYCOBACTERIUM TUBERCULOSIS; PROTEIN STRUCTURE, TERTIARY;

EID: 84908126777     PISSN: 17580463     EISSN: None     Source Type: Journal    
DOI: 10.1093/database/bau035     Document Type: Article

References (57)

1. World Health Organization. (2013) Global Tuberculosis Report Volume 2013.
2. Caminero, J.A., Sotgiu, G., Zumla, A. et al. (2010) Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infec. Dis., 10, 621-629.
3. Koul, A., Arnoult, E., Lounis, N. et al. (2011) The challenge of new drug discovery for tuberculosis. Nature, 469, 483-490.
4. Russell, D.G., Barry, C.E. and Flynn, J.L. (2010) Tuberculosis: what we don't know can, and does, hurt us. Science, 328, 852-856.
5. Lew, J.M., Kapopoulou, A., Jones, L.M. et al. (2011) TubercuList-10 years after. Tuberculosis, 91, 1-7.
6. Reddy, T., Riley, R., Wymore, F. et al. (2009) TB database: an integrated platform for tuberculosis research. Nucleic Acids Res., 37, D499-D508.
7. Aguero, F., Al-Lazikani, B., Aslett, M. et al. (2008) Genomic-scale prioritization of drug targets: the TDR Targets database. Nat. Rev. Drug Discov., 7, 900-907.
8. Schilling, C.H., Schuster, S., Palsson, B.O. et al. (1999) Metabolic pathway analysis: Basic concepts and scientific applications in the post-genomic era. Biotechnol. Prog., 15, 296-303.
9. Schmidtke, P. and Barril, X. (2010) Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. J. Med. Chem., 53, 5858-5867.
10. Hopkins, A.L. and Groom, C.R. (2002) The druggable genome. Nat. Rev. Drug Discov., 1, 727-730.
11. Cheng, A.C., Coleman, R.G., Smyth, K.T. et al. (2007) Structure-based maximal affinity model predicts small-molecule druggability. Nat. Biotech., 25, 71-75.
12. Sheridan, R.P., Maiorov, V.N., Holloway, M.K. et al. (2010) Drug-like density: a method of quantifying the "bindability" of a protein target based on a very large set of pockets and drug-like ligands from the Protein Data Bank. J. Chem. Inf. Model., 50, 2029-2040.
13. Davis, F.P., Barkan, D.T., Eswar, N. et al. (2007) Host-pathogen protein interactions predicted by comparative modeling. Protein Sci., 16, 2585-2596.
14. Kinnings, S.L., Xie, L., Fung, K.H. et al. (2010) The Mycobacterium tuberculosis drugome and its polypharmacological implications. PLoS Comput. Biol., 6, e1000976.
15. Xie, L. and Bourne, P.E. (2007) A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites. BMC Bioinformatics, 8, S9.
16. Halgren, T.A. (2009) Identifying and characterizing binding sites and assessing druggability. J. Chem. Inf. Model., 49, 377-389.
17. Sassetti, C.M., Boyd, D.H. and Rubin, E.J. (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol., 48, 77-84.
18. Sassetti, C.M. and Rubin, E.J. (2003) Genetic requirements for mycobacterial survival during infection. Proc. Natl Acad. Sci. USA, 100, 12989-12994.
19. Rengarajan, J., Bloom, B.R. and Rubin, E.J. (2005) Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc. Natl Acad. Sci. USA, 102, 8327-8332.
20. Jamshidi, N. and Palsson, B.Ø. (2007) Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst. Biol., 1, 26.
21. Raman, K., Rajagopalan, P. and Chandra, N. (2005) Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs. PLoS Comput. Biol., 1, e46.
22. Hasan, S., Daugelat, S., Rao, P.S.S. et al. (2006) Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. PLoS Comput. Biol., 2, 0539-0550.
23. Voskuil, M.I., Bartek, I.L., Visconti, K. et al. (2011) The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front. Microbiol., 2, 105.
24. Betts, J.C., Lukey, P.T., Robb, L.C. et al. (2002) Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol., 43, 717-731.
25. Hampshire, T., Soneji, S., Bacon, J. et al. (2004) Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms? Tuberculosis, 84, 228-238.
26. Muttucumaru, D.G.N., Roberts, G., Hinds, J. et al. (2004) Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis, 84, 239-246.
27. Boshoff, H.I. and Barry, C.E. (2005) Tuberculosis - metabolism and respiration in the absence of growth. Nat. Rev. Microbiol., 3, 70-80.
28. Bairoch, A., Apweiler, R., Wu, C.H. et al. (2005) The universal protein resource (UniProt). Nucleic Acids Res., 33, D154-D159.
29. Johnson, L.S., Eddy, S. and Portugaly, E. (2010) Hidden Markov model speed heuristic and iterative HMM search procedure. BMC Bioinformatics, 11, 431.
30. Altschul, S.F., Gish, W., Miller, W. et al. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
31. Berman, H.M., Battistuz, T., Bhat, T.N. et al. (2002) The Protein Data Bank. Acta Crystallogr. D. Biol. Crystallogr., 58, 899-907.
32. Cole, S.T., Brosch, R., Parkhill, J. et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 393, 537-544.
33. Murphy, D.J. and Brown, J.R. (2007) Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infect. Dis., 7, 84.
34. Griffin, J.E., Gawronski, J.D., DeJesus, M.A. et al. (2011) Highresolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog., 7, e1002251.
35. Li, W. and Godzik, A. (2006) Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics, 22, 1658-1659.
36. Eswar, N., Eramian, D., Webb, B. et al. (2008) Protein structure modeling with MODELLER. Methods Mol. Biol., 426, 145-159.
37. Altschul, S.F., Madden, T.L., Schäffer, A.A. et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 25, 3389-3402.
38. Melo, F. and Sali, A. (2007) Fold assessment for comparative protein structure modeling. Protein Sci., 16, 2412-2426.
39. Benkert, P., Tosatto, S.C. and Schomburg, D. (2008) QMEAN: a comprehensive scoring function for model quality assessment. Proteins, 71, 261-277.
40. Le Guilloux, V., Schmidtke, P. and Tuffery, P. (2009) Fpocket: an open source platform for ligand pocket detection. BMC Bioinformatics, 10, 168.
41. Porter, C.T., Bartlett, G.J. and Thornton, J.M. (2004) The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res., 32, D129-D133.
42. Bateman, A., Coin, L., Durbin, R. et al. (2004) The Pfam protein families database. Nucleic Acids Res., 32, D138-D141.
43. Humphrey, W., Dalke, A. and Schulten, K. (1996) VMD: visual molecular dynamics. J. Mol. Graph., 14, 33-38.
44. DeLano, W.L. (2002) The PyMOL molecular graphics system.
45. Barril, X. (2012) Druggability predictions: methods, limitations, and applications. Wiley Interdiscip. Rev. Comput. Mol. Sci., 3, 327-338
46. Krasowski, A., Muthas, D., Sarkar, A. et al. (2011) DrugPred: a structure-based approach to predict protein druggability developed using an extensive nonredundant data set. J. Chem. Inf. Model., 51, 2829-2842.
47. Henrich, S., Salo-Ahen, O.M., Huang, B. et al. (2010) Computational approaches to identifying and characterizing protein binding sites for ligand design. J. Mol. Recognit., 23, 209-219.
48. Volkamer, A., Griewel, A., Grombacher, T. et al. (2010) Analyzing the topology of active sites: on the prediction of pockets and subpockets. J. Chem. Inf. Model., 50, 2041-2052.
49. Pérot, S., Sperandio, O., Miteva, M.A. et al. (2010) Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov. Today, 15, 656-667.
50. Volkamer, A., Kuhn, D., Grombacher, T. et al. (2012) Combining global and local measures for structure-based druggability predictions. J. Chem. Inf. Model., 52, 360-372.
51. Desaphy, J.R.M., Azdimousa, K., Kellenberger, E. et al. (2012) Comparison and druggability prediction of protein-ligand binding sites from pharmacophore-annotated cavity shapes. J. Chem. Inf. Model., 52, 2287-2299.
52. Perola, E., Herman, L. and Weiss, J. (2012) Development of a rule-based method for the assessment of protein druggability. J. Chem. Inf. Model., 52, 1027-1038.
53. Volkamer, A., Kuhn, D., Rippmann, F. et al. (2012) DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics, 28, 2074-2075.
54. Raman, K., Yeturu, K. and Chandra, N. (2008) targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst. Biol., 2, 109.
55. Jamshidi, N. and Palsson, B.O. (2007) Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst. Biol., 1, 26.
56. Kushwaha, S.K. and Shakya, M. (2010) Protein interaction network analysis - Approach for potential drug target identification in Mycobacterium tuberculosis. J. Theor. Biol., 262, 284-294.
57. Joshi, K.R., Dhiman, H. and Scaria, V. (2013) tbvar: a comprehensive genome variation resource for Mycobacterium tuberculosis. Database, 2013, doi:10.1093/database/bat083.